Clinical Management of Pemphigus
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Dermatology".
Deadline for manuscript submissions: 15 October 2026 | Viewed by 173
Editor
Interests: hereditary epidermolysis bullosa; Hailey–Hailey disease; autoimmune subepidermal bullous diseases; pemphigus; dermatology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Pemphigus, a potentially fatal disease, is still a diagnostic and therapeutic challenge for dermatologists. The introduction of corticosteroids and immunosuppressive drugs in the second half of the 20th century was a milestone in the treatment of pemphigus, but patients treated with this method develop severe systemic complications. The introduction of biological drugs in therapy significantly reduces the complications of aggressive immunosuppression and also contributes to the high effectiveness of the therapy. The list of biological drugs used in the treatment of pemphigus is constantly expanding, and progress in understanding the pathogenesis of pemphigus continues to provide new opportunities to control complex autoimmune processes. Understanding and characterizing the antigens recognized by pemphigus autoantibodies provides a basis not only for modern diagnostics, but also for distinguishing different forms of pemphigus with different clinical courses and responses to treatment. The aim of this Special Issue is to increase awareness of pemphigus and to foster the development of ideal treatments. The articles submitted to this project can be in the form of reviews, original research, or clinical trials related to pemphigus.
Prof. Dr. Cezary Kowalewski
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pemphigus
- pemphigus IgA
- paraneoplastic pemphigus
- cell–cell contact proteins and diagnostic procedures
- novel therapies
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
